Here we demonstrated that lovastatin treatment elevates DR5 expression in all four glioblastoma cell lines including grade IV glioblastoma multiforme (GBM) cell line U87 derived from high-grade gliomas, which are intrinsically TRAIL-resistant. Here, TNFSF10 is linked to central nervous system cancer.